Variant report
Variant | esv1802754 |
---|---|
Chromosome Location | chr8:6827542-6883662 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:60)
- CpG islands (count:611)
- Chromatin interactive region (count:2)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr8:6829807-6830004 | K562 | blood: | n/a | n/a |
2 | BACH1 | chr8:6829927-6829940 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CEBPB | chr8:6872820-6873018 | HepG2 | liver: | n/a | chr8:6872838-6872849 chr8:6872837-6872848 |
4 | CEBPB | chr8:6882761-6882780 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | CEBPB | chr8:6882109-6882181 | A549 | lung: | n/a | n/a |
6 | CTCF | chr8:6829826-6829954 | LNCaP | prostate: | n/a | n/a |
7 | CTCF | chr8:6829420-6829509 | LNCaP | prostate: | n/a | n/a |
8 | CTCF | chr8:6833327-6833368 | Kidney_OC | kidney: | n/a | n/a |
9 | CTCF | chr8:6863352-6863389 | GM13977 | blood: | n/a | n/a |
10 | CTCF | chr8:6827880-6828030 | HEK293 | kidney: | n/a | chr8:6827881-6827890 chr8:6827923-6827930 |
11 | CTCF | chr8:6883380-6883530 | GM12873 | blood: | n/a | n/a |
12 | CTCF | chr8:6830796-6830848 | Lung_OC | lung: | n/a | n/a |
13 | CTCF | chr8:6827929-6828105 | H1-hESC | embryonic stem cell: | n/a | n/a |
14 | CTCF | chr8:6827997-6828044 | Gliobla | brain: | n/a | n/a |
15 | CTCF | chr8:6827960-6828110 | K562 | blood: | n/a | n/a |
16 | CTCF | chr8:6828045-6828050 | Gliobla | brain: | n/a | n/a |
17 | CTCF | chr8:6868755-6868819 | GM13976 | blood: | n/a | n/a |
18 | CTCF | chr8:6829829-6829883 | LNCaP | prostate: | n/a | n/a |
19 | CTCF | chr8:6827996-6828116 | H1-hESC | embryonic stem cell: | n/a | n/a |
20 | CTCF | chr8:6830206-6830256 | Kidney_OC | kidney: | n/a | n/a |
21 | CTCF | chr8:6850725-6850800 | Lung_OC | lung: | n/a | n/a |
22 | CTCF | chr8:6875862-6875906 | Kidney_OC | kidney: | n/a | n/a |
23 | CTCF | chr8:6876641-6876732 | GM13976 | blood: | n/a | n/a |
24 | CTCF | chr8:6870668-6870718 | Lung_OC | lung: | n/a | n/a |
25 | CTCF | chr8:6828040-6828190 | HepG2 | liver: | n/a | n/a |
26 | CTCF | chr8:6832055-6832125 | GM13976 | blood: | n/a | n/a |
27 | CTCF | chr8:6841333-6841432 | GM10248 | blood: | n/a | n/a |
28 | FOS | chr8:6829914-6829972 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | GABPA | chr8:6878604-6878734 | Hela-S3 | cervix: | n/a | n/a |
30 | JUN | chr8:6829918-6830101 | K562 | blood: | n/a | n/a |
31 | JUN | chr8:6829481-6830053 | K562 | blood: | n/a | n/a |
32 | JUND | chr8:6829868-6829984 | H1-hESC | embryonic stem cell: | n/a | n/a |
33 | JUND | chr8:6829930-6830012 | HepG2 | liver: | n/a | n/a |
34 | JUND | chr8:6829760-6830100 | K562 | blood: | n/a | n/a |
35 | JUND | chr8:6829764-6829956 | H1-hESC | embryonic stem cell: | n/a | n/a |
36 | KAP1 | chr8:6829739-6830136 | U2OS | brain: | n/a | n/a |
37 | KAP1 | chr8:6829741-6830106 | HEK293 | kidney: | n/a | n/a |
38 | MAFF | chr8:6829846-6829893 | HepG2 | liver: | n/a | n/a |
39 | MAFK | chr8:6829763-6829959 | H1-hESC | embryonic stem cell: | n/a | chr8:6829896-6829907 chr8:6829896-6829907 chr8:6829891-6829906 |
40 | MAFK | chr8:6829943-6829957 | Hela-S3 | cervix: | n/a | n/a |
41 | MAFK | chr8:6829930-6829935 | HepG2 | liver: | n/a | n/a |
42 | MAFK | chr8:6829787-6829987 | HepG2 | liver: | n/a | chr8:6829896-6829907 chr8:6829896-6829907 chr8:6829891-6829906 |
43 | POLR2A | chr8:6845770-6845778 | MCF-7 | breast: | n/a | n/a |
44 | POLR2A | chr8:6857571-6857648 | Gliobla | brain: | n/a | n/a |
45 | POLR2A | chr8:6845727-6845752 | MCF-7 | breast: | n/a | n/a |
46 | POLR2A | chr8:6838321-6838399 | Gliobla | brain: | n/a | n/a |
47 | POLR2A | chr8:6882752-6882809 | GM12878 | blood: | n/a | n/a |
48 | RAD21 | chr8:6827832-6828150 | H1-hESC | embryonic stem cell: | n/a | n/a |
49 | SETDB1 | chr8:6829763-6830144 | U2OS | brain: | n/a | n/a |
50 | SPI1 | chr8:6837542-6837676 | K562 | blood: | n/a | chr8:6837626-6837639 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:6876695-6876745 | Caco-2 | colon: | n/a |
2 | chr8:6876695-6876745 | Caco-2 | colon: | n/a |
3 | chr8:6838024-6838074 | RPTEC | kidney: | n/a |
4 | chr8:6875661-6875711 | Hela-S3 | cervix: | n/a |
5 | chr8:6876155-6876205 | PrEC | prostate: | n/a |
6 | chr8:6837932-6837982 | PANC-1 | pancreas: | n/a |
7 | chr8:6873754-6873804 | GM12892 | blood: | n/a |
8 | chr8:6828103-6828153 | BJ | skin: | n/a |
9 | chr8:6876695-6876745 | IMR90 | lung: | fetal |
10 | chr8:6876155-6876205 | U87 | brain: | n/a |
11 | chr8:6827800-6827850 | MCF10A-Er-Src | breast: | n/a |
12 | chr8:6876155-6876205 | BJ | skin: | n/a |
13 | chr8:6876155-6876205 | CMK | blood: | n/a |
14 | chr8:6838024-6838074 | MCF-7 | breast: | n/a |
15 | chr8:6876155-6876205 | A549 | lung: | n/a |
16 | chr8:6827800-6827850 | AG04449 | skin: | fetal |
17 | chr8:6837932-6837982 | HRE | kidney: | n/a |
18 | chr8:6827814-6827864 | AG09309 | skin: | n/a |
19 | chr8:6875661-6875711 | AG04450 | lung: | fetal |
20 | chr8:6876695-6876745 | HMEC | breast: | n/a |
21 | chr8:6837932-6837982 | NHDF-neo | bronchial: | n/a |
22 | chr8:6838024-6838074 | HepG2 | liver: | n/a |
23 | chr8:6827800-6827850 | NB4 | blood: | n/a |
24 | chr8:6875661-6875711 | SKMC | muscle: | n/a |
25 | chr8:6827800-6827850 | HepG2 | liver: | n/a |
26 | chr8:6876781-6876831 | MCF10A-Er-Src | breast: | n/a |
27 | chr8:6828103-6828153 | HRE | kidney: | n/a |
28 | chr8:6876155-6876205 | T-47D | breast: | n/a |
29 | chr8:6873754-6873804 | HCPEpiC | choroid plexus: | n/a |
30 | chr8:6827814-6827864 | NT2-D1 | testis: | n/a |
31 | chr8:6876155-6876205 | ovcar-3 | ovarian: | n/a |
32 | chr8:6875661-6875711 | AG10803 | skin: | n/a |
33 | chr8:6837932-6837982 | NB4 | blood: | n/a |
34 | chr8:6875661-6875711 | GM12892 | blood: | n/a |
35 | chr8:6873754-6873804 | K562 | blood: | n/a |
36 | chr8:6828103-6828153 | GM19239 | blood: | n/a |
37 | chr8:6827800-6827850 | K562 | blood: | n/a |
38 | chr8:6876155-6876205 | SAEC | small airway: | n/a |
39 | chr8:6827800-6827850 | NH-A | brain: | n/a |
40 | chr8:6876695-6876745 | HAEpiC | amniotic membrane: | n/a |
41 | chr8:6837932-6837982 | MCF10A-Er-Src | breast: | n/a |
42 | chr8:6827814-6827864 | SAEC | small airway: | n/a |
43 | chr8:6827814-6827864 | HNPCEpiC | eye: | n/a |
44 | chr8:6875661-6875711 | SAEC | small airway: | n/a |
45 | chr8:6838024-6838074 | HAEpiC | amniotic membrane: | n/a |
46 | chr8:6827814-6827864 | NH-A | brain: | n/a |
47 | chr8:6876695-6876745 | HepG2 | liver: | n/a |
48 | chr8:6876781-6876831 | AG04449 | skin: | fetal |
49 | chr8:6828103-6828153 | HRPEpiC | eye: | n/a |
50 | chr8:6827800-6827850 | GM12878 | blood: | n/a |
(count:2 , 50 per page) page:
1
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DEFA1B-1 | chr8:6845622-6845808 | NONHSAT124804 |
2 | lnc-DEFA1B-1 | chr8:6847181-6847243 | NONHSAT124804 |
3 | lnc-DEFA1B-1 | chr8:6844700-6844945 | NONHSAT124804 |
No data |
No data |
Variant related genes | Relation type |
---|---|
DEFA1B | TF binding region |
DEFT1P2 | TF binding region |
DEFA10P | TF binding region |
DEFA1 | TF binding region |
DEFA3 | TF binding region |
DEFT1P | TF binding region |
DEFA1B | CpG island |
DEFT1P2 | CpG island |
DEFA10P | CpG island |
DEFA1 | CpG island |
DEFA3 | CpG island |
DEFT1P | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549167762 | chr8:6827575-6827576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs116781510 | chr8:6827606-6827607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138288846 | chr8:6827617-6827618 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187212707 | chr8:6827618-6827619 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs78147557 | chr8:6827633-6827634 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs199792670 | chr8:6827644-6827645 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs200536587 | chr8:6827658-6827659 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs538287287 | chr8:6827678-6827679 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs375179459 | chr8:6827689-6827690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551788079 | chr8:6827690-6827691 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs201307331 | chr8:6827695-6827696 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs570792219 | chr8:6827708-6827709 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs149584602 | chr8:6827710-6827711 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539333772 | chr8:6827716-6827717 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs2977819 | chr8:6827740-6827741 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs200722988 | chr8:6827748-6827749 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs527404666 | chr8:6827767-6827768 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572919071 | chr8:6827768-6827769 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532469233 | chr8:6827776-6827777 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540082034 | chr8:6827780-6827781 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs373405800 | chr8:6827784-6827785 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs377576405 | chr8:6827794-6827795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs116642893 | chr8:6827814-6827815 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs570394622 | chr8:6827816-6827817 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs192535441 | chr8:6827817-6827818 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs555751480 | chr8:6827818-6827819 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs184569436 | chr8:6827823-6827824 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs2738132 | chr8:6827824-6827825 | Weak transcription Enhancers | CpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs558010388 | chr8:6827834-6827835 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs576624771 | chr8:6827836-6827837 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs545623043 | chr8:6827841-6827842 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs562427621 | chr8:6827844-6827845 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs531519468 | chr8:6827853-6827854 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs541435917 | chr8:6827855-6827856 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs187951098 | chr8:6827906-6827907 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs192424606 | chr8:6827912-6827913 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs10087798 | chr8:6827914-6827915 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs184398293 | chr8:6827926-6827927 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs570587019 | chr8:6827933-6827934 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs199556749 | chr8:6827944-6827945 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs200700871 | chr8:6827955-6827956 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs373109824 | chr8:6827962-6827963 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs377506689 | chr8:6827970-6827971 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs202040794 | chr8:6827977-6827978 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs550411632 | chr8:6827978-6827979 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs189742971 | chr8:6827995-6827996 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs10106288 | chr8:6828022-6828023 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs116882969 | chr8:6828027-6828028 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs117969880 | chr8:6828032-6828033 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs79034871 | chr8:6828034-6828035 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Bladder cancer | 21909424 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Breast cancer | 17142309 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Autism | 21865298 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Behcet''s disease | 22219625 | CNVD |
Crohn''s disease | 21701837 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:6794600-6829200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr8:6822800-6830000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr8:6824600-6828200 | Weak transcription | H1 Cell Line | embryonic stem cell |
4 | chr8:6824800-6829200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr8:6828200-6828600 | Enhancers | H1 Cell Line | embryonic stem cell |
6 | chr8:6828200-6828600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
7 | chr8:6828400-6828600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr8:6828600-6829600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr8:6829200-6829400 | Active TSS | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr8:6829200-6829400 | Enhancers | Right Ventricle | heart |
11 | chr8:6829200-6830200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr8:6829600-6830000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr8:6829600-6830000 | Enhancers | Fetal Brain Male | brain |
14 | chr8:6829600-6830200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
15 | chr8:6829800-6830000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
16 | chr8:6830000-6833000 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
17 | chr8:6831000-6831200 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
18 | chr8:6833000-6833600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
19 | chr8:6833600-6837800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
20 | chr8:6837800-6838200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
21 | chr8:6838200-6840600 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
22 | chr8:6840600-6841800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
23 | chr8:6856800-6857400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
24 | chr8:6863200-6866800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
25 | chr8:6867000-6871800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
26 | chr8:6871800-6873000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
27 | chr8:6872400-6872600 | Enhancers | Primary hematopoietic stem cells | blood |
28 | chr8:6873000-6873400 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
29 | chr8:6873400-6884600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
30 | chr8:6879800-6881200 | Enhancers | Dnd41 | blood |
31 | chr8:6881200-6881400 | Bivalent Enhancer | ES-WA7 Cell Line | embryonic stem cell |
32 | chr8:6882000-6882400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
33 | chr8:6882200-6882400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
34 | chr8:6883200-6883400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |